Liraglutide-associated body composition change: muscle mass loss and determinants
Purpose: We aimed to quantify fat-mass (FM) and muscle-mass (MM) changes over six months of liraglutide therapy and to identify predictors of disproportionate MM decline.Materials and Methods: In this retrospective observational cohort, adults with overweight/obesity receiving liraglutide underwent multifrequency bioelectrical impedance analysis (BIA) at baseline and 6 months. Patients were grouped by weight reduction (
Authors
- Ömercan Topaloğlu (ORCID: https://orcid.org/0000-0003-3703-416X)
- İhsan AYHAN (ORCID: https://orcid.org/0000-0002-7539-2454)
Institutions
- Zonguldak Bülent Ecevit University (TR)
Publication Details
- Journal
- Çukurova medical journal (Online)/Çukurova medical journal
- Published
- 2026-09-30
- DOI
- https://doi.org/10.17826/cumj.1925099
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00